TrialEuropean journal of nuclear medicine and molecular imaging2026

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Wendy Delbart et al.PubMed ↗Publisher ↗

No numbers read from the abstract.